KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Thermo Fisher Scientific (TMO) Net Margin (2016 - 2025)

Thermo Fisher Scientific's Net Margin history spans 17 years, with the latest figure at 16.32% for Q4 2025.

  • For the quarter ending Q4 2025, Net Margin rose 26.0% year-over-year to 16.32%, compared with a TTM value of 15.18% through Dec 2025, up 40.0%, and an annual FY2025 reading of 15.16%, up 38.0% over the prior year.
  • Net Margin for Q4 2025 was 16.32% at Thermo Fisher Scientific, up from 14.49% in the prior quarter.
  • The five-year high for Net Margin was 23.59% in Q2 2021, with the low at 12.04% in Q2 2023.
  • Average Net Margin over 5 years is 15.82%, with a median of 15.19% recorded in 2022.
  • Biggest YoY gain for Net Margin was 1094bps in 2021; the steepest drop was -819bps in 2021.
  • Tracing TMO's Net Margin over 5 years: stood at 15.49% in 2021, then dropped by -11bps to 13.76% in 2022, then rose by 9bps to 14.97% in 2023, then increased by 7bps to 16.06% in 2024, then grew by 2bps to 16.32% in 2025.
  • Per Business Quant, the three most recent readings for TMO's Net Margin are 16.32% (Q4 2025), 14.49% (Q3 2025), and 15.22% (Q2 2025).